Literature DB >> 16049319

Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat.

Tadeusz Pawelczyk1, Marzena Grden, Robert Rzepko, Monika Sakowicz, Andrzej Szutowicz.   

Abstract

Pathological alterations of renal function in insulin-dependent diabetes have been attributed to numerous factors, including adenosine. This study examined the expression levels of adenosine receptors (ARs) in the kidney of the streptozotocin-induced diabetic rat. In the diabetic kidney A1-AR mRNA levels increased 1.7- and 2.8-fold in cortex and medulla, respectively. This was accompanied by increased A1-AR protein levels in membranes of kidney cortex (1.5-fold) and medulla (threefold). A1-AR immunoreactivity increased strongly along medullar tubules especially in the collecting duct. The levels of A2a-AR mRNA increased twofold in diabetic kidney cortex but remained unchanged in medulla; however, A2a-AR protein levels increased more than threefold in cortex. Immunohistochemistry showed increased A2a-AR immunoreactivity in luminal membranes of cortical collecting ducts and in epithelial cells of preglomerular vessels. There were no significant changes in A2b-AR expression in diabetic kidney except in medullar membranes, where the receptor protein content decreased by 60%. A3-AR mRNA levels in diabetic kidney remained unchanged, but membrane-associated A3-AR protein levels increased by 70% in diabetic kidney cortex and decreased by 80% in medulla. These changes in ARs genes expression, receptor protein content, and cellular and tissue distribution, correspond to abnormalities characteristic of the diabetic kidney, suggesting involvement in pathogenesis of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049319      PMCID: PMC1603567          DOI: 10.1016/S0002-9440(10)62977-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  The renal adenosine system: structure, function, and regulation.

Authors:  D E McCoy; S Bhattacharya; B A Olson; D G Levier; L J Arend; W S Spielman
Journal:  Semin Nephrol       Date:  1993-01       Impact factor: 5.299

2.  Vasopressin and urinary concentrating activity in diabetes mellitus.

Authors:  M Ahloulay; F Schmitt; M Déchaux; L Bankir
Journal:  Diabetes Metab       Date:  1999-09       Impact factor: 6.041

3.  An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: its role in attenuating adenosine-induced increase in cAMP.

Authors:  Z Zhao; C E Francis; K Ravid
Journal:  Microvasc Res       Date:  1997-11       Impact factor: 3.514

4.  Renal sodium handling in experimental diabetes: role of NO.

Authors:  R Komers; M E Cooper
Journal:  Nephrol Dial Transplant       Date:  1996-11       Impact factor: 5.992

5.  Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus.

Authors:  P K Carmines; K Ohishi; H Ikenaga
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

6.  Adenosine A1 receptor-mediated inhibition of vasopressin action in inner medullary collecting duct.

Authors:  R M Edwards; W S Spielman
Journal:  Am J Physiol       Date:  1994-05

7.  Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.

Authors:  M R Rudnick; S Goldfarb; L Wexler; P A Ludbrook; M J Murphy; E F Halpern; J A Hill; M Winniford; M B Cohen; D B VanFossen
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

8.  Effects of adenosine on ion transport in rat medullary thick ascending limb.

Authors:  R E Beach; D W Good
Journal:  Am J Physiol       Date:  1992-09

9.  Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction.

Authors:  V Vallon; L M Wead; R C Blantz
Journal:  J Am Soc Nephrol       Date:  1995-04       Impact factor: 10.121

10.  Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats.

Authors:  A C Pflueger; F Schenk; H Osswald
Journal:  Am J Physiol       Date:  1995-10
View more
  24 in total

1.  SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.

Authors:  Xiaoxin X Wang; Jonathan Levi; Yuhuan Luo; Komuraiah Myakala; Michal Herman-Edelstein; Liru Qiu; Dong Wang; Yingqiong Peng; Almut Grenz; Scott Lucia; Evgenia Dobrinskikh; Vivette D D'Agati; Hermann Koepsell; Jeffrey B Kopp; Avi Z Rosenberg; Moshe Levi
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

2.  The extracellular cAMP-adenosine pathway regulates expression of renal D1 dopamine receptors in diabetic rats.

Authors:  Eldo V Kuzhikandathil; Leslie Clark; Ying Li
Journal:  J Biol Chem       Date:  2011-07-29       Impact factor: 5.157

Review 3.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

4.  Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes.

Authors:  Monika Sakowicz-Burkiewicz; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

5.  The identification of gene expression profiles associated with progression of human diabetic neuropathy.

Authors:  Junguk Hur; Kelli A Sullivan; Manjusha Pande; Yu Hong; Anders A F Sima; Hosagrahar V Jagadish; Matthias Kretzler; Eva L Feldman
Journal:  Brain       Date:  2011-09-16       Impact factor: 13.501

6.  Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2017-12-18       Impact factor: 4.432

7.  Candesartan Differentially Regulates Epithelial Sodium Channel in Cortex Versus Medulla of Streptozotocin-Induced Diabetic Rats.

Authors:  Janet D Klein; Arjun Rash; Jeff M Sands; Carolyn M Ecelbarger; Swasti Tiwari
Journal:  J Epithel Biol Pharmacol       Date:  2009-01-01

8.  A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Authors:  Bunyen Teng; Jonathan D Smith; Michael E Rosenfeld; Peggy Robinet; Mary E Davis; R Ray Morrison; S Jamal Mustafa
Journal:  Cardiovasc Res       Date:  2014-02-12       Impact factor: 10.787

9.  Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; Zhichao Zhou; S Jamal Mustafa
Journal:  J Mol Cell Cardiol       Date:  2015-12-02       Impact factor: 5.000

10.  Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.

Authors:  Daniela Patinha; Angelica Fasching; Dora Pinho; António Albino-Teixeira; Manuela Morato; Fredrik Palm
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.